Ganli Pharmaceutical (603087.SH): Glycine insulin injection (cartridge) obtained Salvadoran drug registration approval

Zhitong Finance App News, Ganli Pharmaceutical (603087.SH) issued an announcement. Recently, the company received approval for the registration of insulin glargine injection (cartridge) (approval number: BT004315102026) from the General Administration of Health Supervision of El Salvador. Indications: Used for diabetes treatment in adults, adolescents and children aged 2 and above.